In vivo therapeutic effects of affinity-improved-TCR engineered T-cells on HBV-related hepatocellular carcinomaQi Liu, Yuefei Ren, Peipei Zhou et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 42